Cevdet Samikoglu
Algemeen Directeur bij Biosplice Therapeutics, Inc.
Profiel
Cevdet Samikoglu is currently the Chief Executive Officer and Director at Biosplice Therapeutics, Inc. Prior to this, he worked as a Partner at Greywolf Capital Management LP.
Actieve functies van Cevdet Samikoglu
| Bedrijven | Functie | Begin |
|---|---|---|
Biosplice Therapeutics, Inc.
 Biosplice Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Biosplice Therapeutics, Inc. provides medical research and development for tissue-level regeneration. It develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. The company was founded by Osman Kibar and John Hood in 2008 and is headquartered in San Diego, CA. | Algemeen Directeur | 01-03-2021 |
Eerdere bekende functies van Cevdet Samikoglu
| Bedrijven | Functie | Einde |
|---|---|---|
Greywolf Capital Management LP
 Greywolf Capital Management LP Investment ManagersFinance Greywolf Capital Management LP (Greywolf Capital) is an independent, SEC-registered investment advisor and hedge fund firm headquartered in Purchase, New York. The firm was founded in 2003 by Bob Miller, Jonathan Savitz, William Troy and James Gillespie. Greywolf Capital provides investment advisory services to (i) private investment funds that are primarily offered to institutional investors and financially sophisticated high net worth individuals and (ii) separately managed accounts, primarily for the foregoing types of investors. | Portefeuillebeheerder-Aandelen | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Greywolf Capital Management LP
Greywolf Capital Management LP Investment ManagersFinance Greywolf Capital Management LP (Greywolf Capital) is an independent, SEC-registered investment advisor and hedge fund firm headquartered in Purchase, New York. The firm was founded in 2003 by Bob Miller, Jonathan Savitz, William Troy and James Gillespie. Greywolf Capital provides investment advisory services to (i) private investment funds that are primarily offered to institutional investors and financially sophisticated high net worth individuals and (ii) separately managed accounts, primarily for the foregoing types of investors. | Finance |
Biosplice Therapeutics, Inc.
Biosplice Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Biosplice Therapeutics, Inc. provides medical research and development for tissue-level regeneration. It develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. The company was founded by Osman Kibar and John Hood in 2008 and is headquartered in San Diego, CA. | Commercial Services |
